Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Cash & Equivalents (2016 - 2025)

Enovis (ENOV) has disclosed Cash & Equivalents for 16 consecutive years, with $36.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 24.45% to $36.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.4 million, a 24.45% decrease, with the full-year FY2025 number at $36.4 million, down 24.45% from a year prior.
  • Cash & Equivalents was $36.4 million for Q4 2025 at Enovis, up from $33.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $763.7 million in Q2 2021 to a low of $21.9 million in Q1 2023.
  • A 5-year average of $149.0 million and a median of $41.3 million in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 600.8% in 2021, then tumbled 96.69% in 2023.
  • Enovis' Cash & Equivalents stood at $680.3 million in 2021, then plummeted by 96.43% to $24.3 million in 2022, then skyrocketed by 48.96% to $36.2 million in 2023, then skyrocketed by 33.09% to $48.2 million in 2024, then dropped by 24.45% to $36.4 million in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Cash & Equivalents are $36.4 million (Q4 2025), $33.6 million (Q4 2025), and $44.1 million (Q3 2025).